Pharmaceuticals

The levy would then double a year later, to 200%, in August 2029.

Trump sets 100% tariff on generic drugs with two-year delay

The US president has seized on the cost of drugs as a key driver of affordability concerns ahead of the 2026 midterm elections

2026-07-22T02:23:45.000Z

For the Republic, fostering robust and competitive innovation within the healthcare industry is increasingly becoming a national priority as its population ages.

Companies & Markets

Singapore bets on AI in healthcare, but success will depend on commercial sustainability

Private sector needs to translate AI productivity gains into cost savings for patients, experts say

2026-07-21T08:43:55.000Z

Jiangsu Hengrui Pharmaceuticals’ office in Shanghai, China, June 11, 2026.

Global Enterprise

Chinese drugmakers with big ambitions struggle to recruit staff for global expansion

The industry faces a shortage of specialised manpower

2026-07-16T03:03:08.000Z

AstraZeneca will have the option to obtain exclusive rights to develop, manufacture and commercialise one preclinical small nucleic acid drug candidate globally.

International

AstraZeneca signs CSPC China deal for experimental kidney disease drugs

CSPC is eligible to receive US$30 million as upfront payment and up to US$1.7 billion in additional payments

2026-07-02T13:24:16.000Z

This marks a significant expansion of GSK’s cancer portfolio, which has been slowly growing since it returned to the disease space in 2019.

Consumer & Healthcare

GSK to buy Nuvalent for US$10.6 billion to expand in cancer drugs

The British firm will pay US$124 a share for Nuvalent

2026-06-09T09:05:48.000Z

The transaction is expected to close later this year.

Consumer & Healthcare

J&J to buy cancer drug technology developer Firefly Bio for US$1 billion

JOHNSON & Johnson said on Monday (Jun 8) it will acquire biotech Firefly Bio for US$1 billion in cash, as it looks to expand its cancer drug pipeline.

2026-06-08T12:52:01.000Z

In what appears to be a first, a presentation of a clinical trail conducted exclusively in China will be a headliner at this year's American Society of Clinical Oncology meeting.

International

China’s rise in drug development looms over US

China’s ascendence as a drug development powerhouse could threaten US biotechnology

2026-05-30T06:39:40.000Z

A pharmaceutical firm in India has launched a weight-loss injection that costs from 1,290 rupees (S$17) a month.

Opinion & Features

THINKING ALOUD

A GLP-1 tsunami is headed for the vice industry. Good.

A new wave of cheap weight-loss drugs heralds an existential crisis for the sin economy

2026-05-25T23:15:00.000Z

Sun Pharma, valued at more than US$40 billion, plans to fund the acquisition through a combination of available cash resources and committed financing from banks.

Companies & Markets

India’s Sun Pharma to buy US-listed Organon in about US$11.8 billion deal

Sun Pharma will buy all the outstanding shares of Organon for US$14 per share

2026-04-27T04:03:37.000Z

Zuellig Pharma’s Changi warehouse and distribution centre in Singapore, established in 2009.

Companies & Markets

Competition watchdog seeks public feedback on Zuellig Pharma-Eli Lilly deal

Pact includes Zuellig Pharma getting exclusive rights to make erectile dysfunction drug Cialis in Singapore

2026-04-02T11:23:31.000Z

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News